{"id":506325,"date":"2010-04-13T07:40:37","date_gmt":"2010-04-12T23:40:37","guid":{"rendered":"http:\/\/localhost\/wordpress\/2010\/04\/13\/pharmaceutical\/"},"modified":"2010-04-13T07:40:37","modified_gmt":"2010-04-12T23:40:37","slug":"pharmaceutical","status":"publish","type":"post","link":"https:\/\/ogmacau.com\/?p=506325","title":{"rendered":"Pharmaceutical"},"content":{"rendered":"

\u6fb3\u9580\u885b\u751f\u5c40\u85e5\u7269\u4e8b\u52d9\u5ef3<\/a><\/h2>\n

\u5b63\u5ea6\u85e5\u520b Quarterly Drug Newsletter<\/a><\/p>\n

2009\u5e74\u7b2c\u4e00\u5b63\u5ea6 (2009. No.1)<\/a><\/p>\n

2009\u5e74\u7b2c\u4e8c\u5b63\u5ea6 (2009. No.2)<\/a><\/p>\n

2009\u5e74\u7b2c\u4e09\u5b63\u5ea6 (2009. No.3)<\/a><\/p>\n

2009\u5e74\u7b2c\u56db\u5b63\u5ea6 (2009. No.4)<\/a><\/p>\n

2010\u5e74\u7b2c\u4e00\u5b63\u5ea6 (2010. No. 1)<\/a><\/p>\n

\u95dc\u65bcRotarix\u7684\u6700\u65b0\u8cc7\u8a0a Latest update of Rotarix<\/a><\/p>\n

\u95dc\u65bc\u6297\u7532\u72c0\u817a\u7d20\u85e5\u7269Propylthiouracil\u5b89\u5168\u6027\u7684\u65b0\u8cc7\u8a0a<\/a><\/p>\n

Medication Guide – PROPYLTHIOURACIL<\/a><\/p>\n

\u95dc\u65bc\u4fc3\u6027\u817a\u6fc0\u7d20\u91cb\u653e\u6fc0\u7d20\u5b89\u5168\u6027\u7684\u6700\u65b0\u8cc7\u8a0a Lastest Safety updates on gonadotrophin-releasing hormone (GnRH) agonists<\/a><\/p>\n

\u95dc\u65bc\u975e\u90a3\u96c4\u80fa(finasteride)\u548c\u7d05\u8840\u7403\u751f\u6210\u7d20(Erythropoiesis-stimulating agents, ESAs)\u5b89\u5168\u6027\u7684\u6700\u65b0\u8cc7\u8a0a<\/a><\/p>\n

\u95dc\u65bcExelon\u8cbc\u7247(rivastigmine \u7d93\u76ae\u8cbc\u7247\u5b89\u5168\u6027\u7684\u6700\u65b0\u8cc7\u8a0a Latest Safety update on Exelon patch (rivastigmine transdermal patch)<\/a><\/p>\n

\u95dc\u65bc\u5de6\u7094\u8afe\u5b55\u916e\u5b50\u5bae\u5167\u91cb\u653e\u7cfb\u7d71(Levonorgestrel-Releasing Intrauterine System, Mirena)\u5b89\u5168\u6027\u7684\u6700\u65b0\u8cc7\u8a0a Lasest Safety update on levonorgestrel-Releasing Intrauterine System (Mirena)<\/p>\n

\u95dc\u65bcOlmesartan\u5b89\u5168\u6027\u7684\u6700\u65b0\u8cc7\u8a0a Latest safety update on Olmesartan<\/p>\n

\u95dc\u65bcBevacizumab(avastin)\u8655\u65b9\u6307\u5f15\u7684\u6700\u65b0\u8cc7\u8a0a Latest guidelines on bevacizumab (Avastin) <\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u6fb3\u9580\u885b\u751f\u5c40\u85e5\u7269\u4e8b\u52d9\u5ef3 \u5b63\u5ea6\u85e5\u520b Quarterly Drug Newsletter 2009\u5e74\u7b2c\u4e00\u5b63\u5ea6 (20 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[69],"tags":[],"class_list":["post-506325","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/ogmacau.com\/index.php?rest_route=\/wp\/v2\/posts\/506325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogmacau.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogmacau.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogmacau.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ogmacau.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=506325"}],"version-history":[{"count":0,"href":"https:\/\/ogmacau.com\/index.php?rest_route=\/wp\/v2\/posts\/506325\/revisions"}],"wp:attachment":[{"href":"https:\/\/ogmacau.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=506325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogmacau.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=506325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogmacau.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=506325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}